Demo Sign up Log In

Regeneron Pharmaceuticals (REGN)

Interest Expense

$55.40M

TTM · Period ending: Jun 30, 2026 · USD

REGN Interest Expense

Latest reported$55.40Mperiod endingJun 30, 2026

Latest reported$55.40Mperiod endingJun 30, 2026

REGN TTM Interest Expense ($0.00 → $55.40M)

TTM interest expense

High-resolution chart · PNG

REGN interest expense history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Interest Expense — Trailing twelve months (TTM) (USD)
Period ending	Interest Expense (USD)
Jun 30, 2001	7,092,000
Mar 31, 2001	7,092,000
Dec 31, 2000	7,092,000
Sep 30, 2000	500,000
Jun 30, 2000	500,000
Mar 31, 2000	500,000
Dec 31, 1999	500,000
Sep 30, 1999	0
Jun 30, 1999	0
Mar 31, 1999	0
Dec 31, 1998	0
Sep 30, 1998	600,000
Jun 30, 1998	1,300,000
Mar 31, 1998	1,800,000
Dec 31, 1997	3,500,000
Sep 30, 1997	6,500,000
Jun 30, 1997	10,100,000
Mar 31, 1997	13,200,000
Dec 31, 1996	14,300,000
Sep 30, 1996	15,600,000
Jun 30, 1996	15,800,000
Mar 31, 1996	15,000,000
Dec 31, 1995	13,900,000
Sep 30, 1995	9,000,000
Jun 30, 1995	4,500,000
Mar 31, 1995	1,700,000
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.